Deidre Roniger has more than 20 years of biotech experience. She is currently SVP of Corporate Development at Ambys Medicines. Throughout her career, she has had P&L responsibility for a $250 million franchise, managed a cost center of $75 million and been accountable for the accurate forecasting and analytical support of Genentech’s $6 billion portfolio of products when was the head of Genentech’s Market Analysis & Intelligence group. Most recently, she was a Partner at DNA Ink for 10 years.
Deidre earned an MBA from Wake Forest University and holds a BS in Biochemistry from the University of California at San Diego. In 2007, she was named Healthcare Business Women’s Association Rising Star.
Deidre spends as much time as possible in New Orleans with her husband and two children and is an avid fan of the New Orleans Saints.
